Skip to main content

The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.

Publication ,  Journal Article
Chui, SY; Clay, TM; Lyerly, HK; Morse, MA
Published in: Cancer Epidemiol Biomarkers Prev
August 2005

Gastric cancer is one of the most important worldwide public health problems. Convincing epidemiologic and etiologic associations have been made between the development of gastric cancer and infection with Helicobacter pylori. H. pylori not only has adapted to survive within the harsh environment of the stomach but also is able to modulate and avoid endogenous immune responses. The design and creation of efficacious vaccine strategies against H. pylori requires an understanding of the complex interactions that make up mucosal immunity. An effective vaccine strategy against H. pylori has the potential to affect significantly on population health worldwide.

Duke Scholars

Published In

Cancer Epidemiol Biomarkers Prev

DOI

ISSN

1055-9965

Publication Date

August 2005

Volume

14

Issue

8

Start / End Page

1883 / 1889

Location

United States

Related Subject Headings

  • Stomach Neoplasms
  • Humans
  • Helicobacter pylori
  • Helicobacter Infections
  • Epidemiology
  • Cancer Vaccines
  • Bacterial Vaccines
  • Bacterial Proteins
  • Antigens, Bacterial
  • Adenocarcinoma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chui, S. Y., Clay, T. M., Lyerly, H. K., & Morse, M. A. (2005). The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. Cancer Epidemiol Biomarkers Prev, 14(8), 1883–1889. https://doi.org/10.1158/1055-9965.EPI-04-0775
Chui, Stephen Y., Timothy M. Clay, H Kim Lyerly, and Michael A. Morse. “The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.Cancer Epidemiol Biomarkers Prev 14, no. 8 (August 2005): 1883–89. https://doi.org/10.1158/1055-9965.EPI-04-0775.
Chui SY, Clay TM, Lyerly HK, Morse MA. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1883–9.
Chui, Stephen Y., et al. “The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.Cancer Epidemiol Biomarkers Prev, vol. 14, no. 8, Aug. 2005, pp. 1883–89. Pubmed, doi:10.1158/1055-9965.EPI-04-0775.
Chui SY, Clay TM, Lyerly HK, Morse MA. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1883–1889.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

ISSN

1055-9965

Publication Date

August 2005

Volume

14

Issue

8

Start / End Page

1883 / 1889

Location

United States

Related Subject Headings

  • Stomach Neoplasms
  • Humans
  • Helicobacter pylori
  • Helicobacter Infections
  • Epidemiology
  • Cancer Vaccines
  • Bacterial Vaccines
  • Bacterial Proteins
  • Antigens, Bacterial
  • Adenocarcinoma